Lin Yang Selected Research

silver sulfide

9/2019	Silver sulfide nanoparticles for photodynamic therapy of human lymphoma cells via disruption of energy metabolism.
7/2008	Shape-controlled synthesis of protein-conjugated silver sulfide nanocrystals and study on the inhibition of tumor cell viability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lin Yang Research Topics

Disease

297	Neoplasms (Cancer) 11/2022 - 09/2002
51	Inflammation (Inflammations) 08/2022 - 12/2004
51	Neoplasm Metastasis (Metastasis) 04/2022 - 12/2004
40	Stomach Neoplasms (Stomach Cancer) 02/2022 - 04/2002
35	Breast Neoplasms (Breast Cancer) 11/2022 - 01/2007
35	Prostatic Neoplasms (Prostate Cancer) 05/2021 - 06/2003
27	Hepatocellular Carcinoma (Hepatoma) 08/2022 - 02/2004
26	Adenocarcinoma of Lung 01/2021 - 09/2006
25	Infections 05/2022 - 05/2007
25	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2006
24	Pain (Aches) 06/2022 - 04/2004
23	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2022 - 01/2003
23	Carcinogenesis 01/2022 - 01/2003
22	Lung Neoplasms (Lung Cancer) 01/2021 - 05/2002
21	Carcinoma (Carcinomatosis) 05/2022 - 03/2002
21	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2003
21	Hypoxia (Hypoxemia) 01/2022 - 06/2011
21	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 12/2007
20	Latent Autoimmune Diabetes in Adults 01/2021 - 01/2003
19	Hypertension (High Blood Pressure) 06/2022 - 01/2003
19	COVID-19 06/2022 - 01/2020
19	Fibrosis (Cirrhosis) 01/2022 - 07/2008
18	Body Weight (Weight, Body) 08/2022 - 04/2005
16	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2022 - 12/2005
16	Adenocarcinoma 10/2021 - 10/2011
16	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 02/2006
14	Obesity 01/2022 - 04/2009
13	Lymphoma (Lymphomas) 02/2022 - 03/2009
13	Glioma (Gliomas) 12/2021 - 09/2006
12	Liver Cirrhosis (Hepatic Cirrhosis) 03/2022 - 06/2009
12	Necrosis 01/2022 - 04/2007
12	Osteoarthritis 12/2021 - 06/2009
12	Leukemia 10/2021 - 12/2005
12	Colonic Neoplasms (Colon Cancer) 11/2020 - 05/2004
11	Coronary Disease (Coronary Heart Disease) 06/2022 - 10/2012
11	Pneumonia (Pneumonitis) 06/2022 - 07/2015
11	Stroke (Strokes) 12/2021 - 11/2009
11	Myocardial Infarction 11/2021 - 01/2013
11	Human Influenza (Influenza) 03/2021 - 01/2008
10	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 01/2012
10	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 09/2005
10	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 03/2007
10	Fatigue 11/2021 - 07/2008
10	Nasopharyngeal Carcinoma 11/2021 - 02/2014
10	Atherosclerosis 01/2021 - 04/2005
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2022 - 12/2003
9	Osteoporosis 02/2022 - 09/2003
9	Insulin Resistance 01/2022 - 01/2005
9	Rectal Neoplasms (Rectal Cancer) 01/2022 - 06/2015

Drug/Important Bio-Agent (IBA)

95	Proteins (Proteins, Gene)FDA Link 08/2022 - 09/2002
63	Biomarkers (Surrogate Marker)IBA 06/2022 - 07/2006
58	Pharmaceutical PreparationsIBA 01/2022 - 09/2003
29	Messenger RNA (mRNA)IBA 01/2022 - 01/2004
27	Biological ProductsIBA 02/2022 - 01/2003
26	CytokinesIBA 12/2022 - 06/2012
22	EnzymesIBA 01/2022 - 03/2004
20	AutoantibodiesIBA 01/2022 - 11/2003
20	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2004
19	Long Noncoding RNAIBA 08/2022 - 01/2015
19	MicroRNAs (MicroRNA)IBA 01/2022 - 02/2011
17	Transcription Factors (Transcription Factor)IBA 07/2022 - 11/2004
17	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2007
16	Interleukin-6 (Interleukin 6)IBA 12/2022 - 06/2003
16	Therapeutic UsesIBA 11/2022 - 02/2007
16	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2011
16	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 04/2007
15	AntigensIBA 12/2021 - 11/2006
15	VaccinesIBA 11/2021 - 09/2002
15	ErbB Receptors (EGF Receptor)IBA 01/2021 - 03/2007
14	Insulin (Novolin)FDA Link 04/2022 - 01/2003
13	Oxygen (Dioxygen)IBA 06/2022 - 01/2012
13	LigandsIBA 01/2022 - 12/2004
12	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
12	Phosphotransferases (Kinase)IBA 01/2022 - 04/2003
12	Small Interfering RNA (siRNA)IBA 11/2021 - 06/2008
12	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 12/2004
12	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2021 - 01/2003
11	salicylhydroxamic acid (SHAM)IBA 08/2022 - 05/2008
11	Tyrosine Kinase InhibitorsIBA 05/2022 - 05/2014
11	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2010
11	AntibodiesIBA 11/2021 - 06/2004
11	C-Reactive ProteinIBA 01/2021 - 01/2005
11	Androgen Receptors (Androgen Receptor)IBA 02/2019 - 06/2003
10	CholesterolIBA 06/2022 - 04/2005
10	InterferonsIBA 04/2022 - 06/2012
10	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2008
10	Peptides (Polypeptides)IBA 01/2022 - 10/2012
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2003
9	SodiumIBA 01/2022 - 08/2009

Therapy/Procedure

142	Therapeutics 07/2022 - 07/2003
62	Drug Therapy (Chemotherapy) 01/2022 - 12/2004
28	Radiotherapy 02/2022 - 12/2005
23	Immunotherapy 07/2022 - 05/2015
17	Neoadjuvant Therapy 01/2022 - 06/2012
13	Ligation 01/2022 - 06/2009
13	Transplantation 12/2021 - 04/2014
12	Aftercare (After-Treatment) 10/2021 - 10/2008
10	Chemoradiotherapy 01/2022 - 09/2010
9	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2022 - 11/2017
9	Lasers (Laser) 02/2022 - 05/2007